FDA NDC Directory · JSON-LD · Markdown

Avzivi

NDC 82143-002 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic namebevacizumab-tnjn
Labeler / ManufacturerBio-Thera Solutions, Ltd.
Marketing categoryBiologic License Application · App BLA761198
Dosage form / routeINJECTION, SOLUTION · INTRAVENOUS
Active ingredientsBEVACIZUMAB-TNJN (400 mg/16mL)
Marketing started20250101
Package count1

External sources

Source: openFDA. Public-domain (CC0).